S
Evan Morris
VP, Government Affairs and Public Policy, Roche
SECRET TO SUCCESS: "It's what you know, not who you know"
SECRET: "I'm a crummy golfer"
After training at DC's policy-and-lobbying powerhouse Patton Boggs, self-described "food and drug lawyer" Evan Morris joined Roche—and the industry—in January 2005. Having watched his mom beat breast cancer, he was inspired to play on the pharma team. "That was before FDA became managed through Congress," he says by way of acknowledging his baptism by partisan fire. Morris has led Roche's Washington office in negotiating policy for flu preparedness, hep C access, and Medicare and Medicaid. The just-barely-thirtysomething Morris is already an old hand inside the beltway. A White House intern at 18, he learned a lasting lesson from his boss, the deputy chief of staff: "'Speak truth to power, no matter how powerful the individual or how ugly the truth.' At the end of the day, that's how I want to be known."
Evan Morris
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.